Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 5Other hematologic neoplasm 1Other 1Lymphoid 1Gastrointestinal 1

Conditions

Colonic Neoplasms 1

Interventions

Oxaliplatin 151Fluorouracil 136Gemcitabine 117Bevacizumab 114Specimen Handling 104Leucovorin 104Capecitabine 95pembrolizumab 90Magnetic Resonance Spectroscopy 82Nivolumab 79Cisplatin 79Irinotecan 69durvalumab 63Cetuximab 61Paclitaxel 60Biopsy 60130-nm albumin-bound paclitaxel 58Radiotherapy 46atezolizumab 44Albumin-Bound Paclitaxel 37Taxes 36Carboplatin 36Folfox protocol 34Drug Therapy 32lenvatinib 29dehydroftorafur 29Cyclophosphamide 28tislelizumab 27sintilimab 27Radiation 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cholecalciferol × Gastrointestinal × 90 days × Clear all
NCT02172651 2026-05-13

Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases

Dana-Farber Cancer Institute

Phase EARLY_PHASE1 Recruiting
80 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡